ROIV Stock Analysis: Buy, Sell, or Hold?
ROIV - Roivant Sciences Ltd. Common Shares
$34.79
-1.18 (-3.28%)
▼
5d:
-1.7%
30d:
+22.46%
90d:
+23.33%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 10, 2026
27d
Smart Money Accumulation
None View Scanner →
Strength: 6.8/10
Get Alerted When ROIV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ROIV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ROIV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ROIV is currently trading at $34.79, which is considered slightly high relative to its 30-day fair value range of $29.83 to $35.40.
Technical Outlook: Technically, ROIV is in a uptrend. Immediate support is located at $33.61, while resistance sits at $37.00. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: ROIV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ROIV is in a uptrend. Immediate support is located at $33.61, while resistance sits at $37.00. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: ROIV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$29.83 -
$35.40
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- NEUTRAL: Near Wall St target ($39.38)
Trading Range Analysis
30-Day Trading Range
$29.83 -
$35.40
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$33.61
Resistance Level
$37.00
Current Trend
Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-31.04
Wall Street Target
$39.38
(+9.5%)
Revenue Growth (YoY)
-66.7%
Earnings Growth (YoY)
-96.1%
Share & Embed Analysis
Last updated: July 13, 2026 12:43 PM ET
Data refreshes hourly during market hours. Next update: 1:43 PM
Data refreshes hourly during market hours. Next update: 1:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ROIV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Venker
SELL
200000 shares
2026-04-20
Matthew Gline
SELL
289774 shares
2026-04-16
Jennifer Humes
SELL
13538 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 63 BUY |
Advanced ROIV Option Strategies
Professional options setups generated by AI based on today's ROIV price and gamma walls.
